Clinical Trials Browser

OTHER × Interventional × Hand-Foot Syndrome × Clear all

NCT05165069 2026-02-02

The Efficacy and Safety of Mecobalamin in the Prevention of Capecitabine Induced Hand Foot Syndrome

Phase 3 Active not recruiting

Breast Neoplasms, Hand-Foot Syndrome

NCT06602167 2024-12-12

Electroacupuncture Combined With Self-administered Acupressure for the Prevention of Capecitabine-Associated Hand-Foot Syndrome

Phase NA Recruiting

BreastGastrointestinal

Breast Neoplasms, Gastrointestinal Neoplasms, Hand-Foot Syndrome

NCT06583369 2024-09-04

The Efficacy and Safety of Liangxue Ointment in the Treatment of Hand-foot Syndrome Caused by VEGFR-TKI Drugs

Phase NA Recruiting

DermatologicGenitourinary

Carcinoma, Renal Cell, Melanoma, Hand-Foot Syndrome

NCT06441513 2024-06-04

The Preventive Effect of Chemotherapy-induced Hand-foot Syndrome

Phase NA Recruiting

Neoplasms, Hand-Foot Syndrome

NCT05755646 2024-05-24

WIn-HFS

Phase NA Completed

Breast Neoplasms, Hand-Foot Syndrome

NCT05641246 2024-01-03

Effect of Topical Diclofenac on Clinical Outcome in Breast Cancer Patients Treated With Capecitabine

Phase 2 Completed

Breast Neoplasms, Hand-Foot Syndrome

NCT04979078 2023-06-18

DermLight

Phase NA Recruiting

Neoplasms, Hand-Foot Syndrome

NCT05327751 2022-04-14

HFS

Phase 3 Unknown

Gastrointestinal

Colorectal Neoplasms, Hand-Foot Syndrome

NCT00751101 2020-10-05

Nicotine Patches in Reducing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine For Metastatic Breast Cancer

Phase 2 Terminated

24 enrolled 12 charts

Breast Neoplasms, Hand-Foot Syndrome

NCT02794493 2019-07-25

Treatment of Hand and Foot Syndrome With Traditional Chinese Medicine Formula LC09 in Patients Who Are Receiving Capecitabine for Colorectal and/or Breast Cancer

Phase 3 Completed

Hand-Foot Syndrome

NCT03173365 2019-01-09

BRIMOCAN

Phase 2 Terminated

Hand-Foot Syndrome

NCT01918852 2018-03-14

SALTO

Phase 3 Completed

Gastrointestinal

Neoplasm Metastasis, Colorectal Neoplasms, Hand-Foot Syndrome

NCT00486213 2015-09-24

Pyridoxine in Preventing Hand-Foot Syndrome Caused by Capecitabine in Patients With Cancer

Phase 3 Terminated

Hand-Foot Syndrome

NCT01291628 2012-01-19

Prevention of Capecitabine Induced Hand and Foot Syndrome

Phase NA Unknown

Neoplasms, Hand-Foot Syndrome